Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Davidzon

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Molecular Imaging and Biology|August 14, 2020
Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[<sup>18</sup>F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with ImmunotherapyRyusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Nuclear Medicine AI in Action: The Bethesda Report (AI Summit 2024)Arman Rahmim, Tyler J Bradshaw, Guido Davidzon, et al.
Archives of Neurology|January 16, 2008
Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1Silvio Ferraris, Susanna Clark, Emanuela Garelli, et al.
Neuroradiology|April 1, 2026
[<sup>18</sup>F]DASA-23 PET/MRI evaluation in newly-diagnosed and recurrent high-grade gliomaAlexander Khalaf, Lewis Naya, Lesley Flynt, et al.
Journal of Psychiatric Research|March 19, 2023
Reductions in synaptic marker SV2A in early-course SchizophreniaJong H Yoon, Zhener Zhang, Elizabeth Mormino, et al.
Journal of Medical Internet Research|December 22, 2016
Bridging the Health Data DivideLeo Anthony Celi, Guido Davidzon, Alistair Ew Johnson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2024
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancerHong Song, Maria Isabel Leonio, Valentina Ferri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2021
A Clinical PET Imaging Tracer ([<sup>18</sup>F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in GlioblastomaCorinne Beinat, Chirag B Patel, Tom Haywood, et al.
Alzheimer'S Research & Therapy|November 12, 2022
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's diseaseEdward N Wilson, Christina B Young, Javier Ramos Benitez, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Molecular Imaging and Biology|August 14, 2020
Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[<sup>18</sup>F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with ImmunotherapyRyusuke Nakamoto, Lisa C Zaba, Jarrett Rosenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
Nuclear Medicine AI in Action: The Bethesda Report (AI Summit 2024)Arman Rahmim, Tyler J Bradshaw, Guido Davidzon, et al.
Archives of Neurology|January 16, 2008
Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1Silvio Ferraris, Susanna Clark, Emanuela Garelli, et al.
Neuroradiology|April 1, 2026
[<sup>18</sup>F]DASA-23 PET/MRI evaluation in newly-diagnosed and recurrent high-grade gliomaAlexander Khalaf, Lewis Naya, Lesley Flynt, et al.
Journal of Psychiatric Research|March 19, 2023
Reductions in synaptic marker SV2A in early-course SchizophreniaJong H Yoon, Zhener Zhang, Elizabeth Mormino, et al.
Journal of Medical Internet Research|December 22, 2016
Bridging the Health Data DivideLeo Anthony Celi, Guido Davidzon, Alistair Ew Johnson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 18, 2024
Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancerHong Song, Maria Isabel Leonio, Valentina Ferri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2021
A Clinical PET Imaging Tracer ([<sup>18</sup>F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in GlioblastomaCorinne Beinat, Chirag B Patel, Tom Haywood, et al.
Alzheimer'S Research & Therapy|November 12, 2022
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's diseaseEdward N Wilson, Christina B Young, Javier Ramos Benitez, et al.
Pageof 5